Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Perioperative Lidocaine in Enhanced Recovery After Major Non-Cardiac Surgery

Official title: The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Non-Cardiac Surgery (IMPALA ERAS)

Run by Vanderbilt University Medical Center · NCT07224711 · Data updated 2026-11-12

This trial tests whether giving IV lidocaine during major non-cardiac surgery helps recovery and reduces opioid use in adults within an ERAS program.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment2290 (estimated)
SponsorVanderbilt University Medical Center
Academic / other
Locations1 site (Nashville, Tennessee)
StatusRecruiting
StartedOctober 26, 2026
Main results expectedOctober 31, 2028
Study endsOctober 31, 2028
Registry record updatedNovember 2, 2026
Trial IDNCT07224711 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) undergoing major elective non-cardiac surgery in colorectal, emergency general surgery, urology, ventral hernia, surgical oncology, or spine services, within the Vanderbilt ERAS program.

Probably not a fit

Patients who have contraindications to lidocaine, undergo emergent or same-day surgery, or receive a regional or epidural pain regimen may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, pragmatic, randomized, blinded, placebo-controlled trial assessing the effect of perioperative intravenous lidocaine within an ERAS pathway on outcomes after major non-cardiac surgery. Participants receive lidocaine HCl 0.8% in D5W as part of multimodal pain management. The study compares hospital length of stay adjusted for patient mix, inpatient opioid use, pain levels, return of bowel function, nausea, infections, ICU transfers, and other surgical outcomes, while monitoring for adverse effects. Eligible patients are adults (18+) undergoing major elective non-cardiac surgery in specified specialties, with ASA I–IV; several contraindications apply. The primary sponsor is Vanderbilt University Medical Center.

Why it matters

Potential benefit: If successful, patients may experience shorter hospital stays and lower opioid needs after major non-cardiac surgery.

How similar studies have gone: Previous evidence suggests perioperative lidocaine can reduce pain and opioid use in some surgical populations, but results vary by setting and protocol.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* Age greater than or equal to 18
* American Society of Anesthesiologists (ASA) class I-IV
* Presenting for major elective, non-cardiac surgery on the colorectal, emergency general surgery, urology, ventral hernia, surgical oncology, or spine services on a weekday
* First surgery in the study period (if a patient has multiple surgeries, only the first will be included)

Exclusion criteria:

* ASA class \>IV
* Emergent procedures
* Allergy or any contraindication to lidocaine infusion
* Patient refusal
* Unable to receive or refusal to receive a regional nerve block
* Patients who receive an epidural due to standard of care
* Direct transfer from operating room to ICU with endotracheal tube in place
* Treating team determines patient ineligible prior to study drug administration
* Same day surgery
* Pregnancy (all female patient of child-bearing age will undergo a pregnancy test the day of surgery)

Where it's running

  • Vanderbilt University Medical Center
    Nashville, Tennessee, United States
    Recruiting

Study contacts

  • Principal investigator: Danial Shams, MD — Vanderbilt University Medical Center
  • Study coordinator: Danial Shams, MD
  • Email: danial.shams@vumc.org
  • Phone: 615-936-3198

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.